Telcon Inc
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
Telcon Inc (200230) - Net Assets
Latest net assets as of September 2025: ₩102.01 Billion KRW
Based on the latest financial reports, Telcon Inc (200230) has net assets worth ₩102.01 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩156.55 Billion) and total liabilities (₩54.54 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩102.01 Billion |
| % of Total Assets | 65.16% |
| Annual Growth Rate | 12.61% |
| 5-Year Change | -8.98% |
| 10-Year Change | 88.98% |
| Growth Volatility | 37.99 |
Telcon Inc - Net Assets Trend (2013–2024)
This chart illustrates how Telcon Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Telcon Inc (2013–2024)
The table below shows the annual net assets of Telcon Inc from 2013 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩83.13 Billion | -20.78% |
| 2023-12-31 | ₩104.94 Billion | +24.75% |
| 2022-12-31 | ₩84.12 Billion | -21.07% |
| 2021-12-31 | ₩106.58 Billion | +16.69% |
| 2020-12-31 | ₩91.34 Billion | -19.89% |
| 2019-12-31 | ₩114.02 Billion | -25.98% |
| 2018-12-31 | ₩154.03 Billion | +43.04% |
| 2017-12-31 | ₩107.69 Billion | +63.26% |
| 2016-12-31 | ₩65.96 Billion | +49.93% |
| 2015-12-31 | ₩43.99 Billion | +1.81% |
| 2014-12-31 | ₩43.21 Billion | +91.98% |
| 2013-12-31 | ₩22.51 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Telcon Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 135964.4% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ₩263.29 Billion | 317.87% |
| Total Equity | ₩82.83 Billion | 100.00% |
Telcon Inc Competitors by Market Cap
The table below lists competitors of Telcon Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hookipa Pharma Inc
NASDAQ:HOOK
|
$12.33 Million |
|
SAGA PURE ASA NK 1
F:SAT
|
$12.33 Million |
|
Tron Inc.
NASDAQ:TRON
|
$12.33 Million |
|
Arrow Syndicate Public Company Limited
BK:ARROW
|
$12.34 Million |
|
DMS S.A. INH. EO 11845
F:DMS1
|
$12.33 Million |
|
Bintai Kinden Corporation Bhd
KLSE:6998
|
$12.31 Million |
|
Eastern Platinum Limited
PINK:ELRFF
|
$12.31 Million |
|
Mlk Foods Public Company Ltd
WAR:MLK
|
$12.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Telcon Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 104,459,071,130 to 82,829,551,340, a change of -21,629,519,790 (-20.7%).
- Net loss of 26,319,870,060 reduced equity.
- Other factors increased equity by 4,690,350,270.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩-26.32 Billion | -31.78% |
| Other Changes | ₩4.69 Billion | +5.66% |
| Total Change | ₩- | -20.71% |
Book Value vs Market Value Analysis
This analysis compares Telcon Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.42x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.68x to 0.42x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩1135.34 | ₩772.00 | x |
| 2017-12-31 | ₩1481.07 | ₩772.00 | x |
| 2018-12-31 | ₩1870.88 | ₩772.00 | x |
| 2019-12-31 | ₩1337.00 | ₩772.00 | x |
| 2020-12-31 | ₩1043.77 | ₩772.00 | x |
| 2021-12-31 | ₩1066.77 | ₩772.00 | x |
| 2022-12-31 | ₩774.58 | ₩772.00 | x |
| 2023-12-31 | ₩933.66 | ₩772.00 | x |
| 2024-12-31 | ₩1858.40 | ₩772.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Telcon Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -31.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -69.51%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 1.85x
- Recent ROE (-31.78%) is below the historical average (-17.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 15.60% | 11.47% | 1.23x | 1.11x | ₩2.42 Billion |
| 2015 | 0.79% | 1.22% | 0.59x | 1.09x | ₩-4.05 Billion |
| 2016 | -5.21% | -11.52% | 0.24x | 1.89x | ₩-10.03 Billion |
| 2017 | -15.27% | -39.95% | 0.20x | 1.95x | ₩-27.21 Billion |
| 2018 | -8.93% | -23.83% | 0.32x | 1.18x | ₩-29.16 Billion |
| 2019 | -46.18% | -93.03% | 0.43x | 1.15x | ₩-64.05 Billion |
| 2020 | -47.14% | -129.91% | 0.18x | 2.03x | ₩-52.19 Billion |
| 2021 | -21.67% | -61.04% | 0.23x | 1.58x | ₩-33.76 Billion |
| 2022 | -50.03% | -151.22% | 0.23x | 1.42x | ₩-50.50 Billion |
| 2023 | 13.31% | 38.30% | 0.26x | 1.34x | ₩3.46 Billion |
| 2024 | -31.78% | -69.51% | 0.25x | 1.85x | ₩-34.60 Billion |
Industry Comparison
This section compares Telcon Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $185,563,423,740
- Average return on equity (ROE) among peers: 1.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Telcon Inc (200230) | ₩102.01 Billion | 15.60% | 0.53x | $12.33 Million |
| Dongwha Pharm.Co.Ltd (000020) | $229.73 Billion | 2.15% | 0.36x | $75.32 Million |
| Yuhan Corp. (000100) | $323.58 Billion | 10.19% | 0.72x | $4.21 Billion |
| Yuyu Pharma Inc (000227) | $128.69 Billion | -1.72% | 0.50x | $26.44 Million |
| Ildong Holdings Co Ltd (000230) | $66.98 Billion | 10.88% | 1.80x | $49.55 Million |
| Samil Pharm (000520) | $62.87 Billion | 0.00% | 0.77x | $110.58 Million |
| Donga Socio Holdings (000640) | $328.69 Billion | 10.58% | 1.17x | $206.35 Million |
| Jw Pharmac (001060) | $223.83 Billion | 0.28% | 1.65x | $278.34 Million |
| JW Pharmaceutical Corp (001067) | $265.44 Billion | 13.94% | 1.43x | $489.75 Million |
| Samsung Pharm (001360) | $77.58 Billion | -31.98% | 0.20x | $65.82 Million |
| Ahn-Gook Pharmaceutical Co. Ltd (001540) | $148.25 Billion | 1.71% | 0.47x | $27.39 Million |